Summary The spontaneous expression of HLA class I and class II molecules in two human breast carcinoma cell lines (MCF7, T47D) and their modulation during epidermal growth factor treatment are reported. Transcription was analysed by Northern blot and hybridisation with HLA class II and class I cDNA specific probes. The expression of cell surface determinants was examined by internal protein labelling with 35s-methionine, immunoprecipitation with monoclonal antibodies specific for HLA class I or class II, followed by isolation of the immune complex on protein A-Sepharose; at least a quantification of glycoproteins was performed by chromatofocusing. Glycoprotein quantification showed a significant increase of HLA class I and class II (DR) antigen expression after stimulation by epidermal growth factor (0.02 gg ml-') in the two cell lines, when compared with untreated cell controls. However, with epidermal growth factor treatment of MCF7 and T47D cells, low increases in the amounts of HLA class I and class II RNA were obtained. These differences between expressed antigens and correspondent RNA amounts would be explained by the fact that EGF in these two cell lines acts more in post-transcription for HLA class I and class II antigens.
HLA class I and class II molecules regulate the overall immune response by mediating interactions among various immunocompetent cells. Class I molecules serve as restriction elements for T-cell-mediated cytotoxicity (Zinkernagel, 1979) and class II molecules are required for the presentation of the antigen to the helper T cell (Benaceraf, 1988) . In normal tissues, HLA class I antigens (Ags) are expressed by most nucleated cells (Ploegh et al., 1981) , while HLA class II have a more restricted pattern of expression. They were first reported to be associated with the hematopoietic and immune lineage and, more recently, have been described in a variety of normal cells, either resting or activated (Radka et al., 1986) .
In tumoral tissues, HLA class I and class II expression is extremely variable, but of importance. The presence of HLA class I molecules is inversely correlated with the degree of tumorigenicity in some animal models (Pfizenmaier et al., 1985) , and HLA class II are known to play a role in the interaction between the host's immune system and tumour cells (Ferrone, 1982) .
In the breast gland, while normal resting mammary tissue expresses class I but not class II antigens, these class II are found on glandular cells during lactation, where they are expressed on the milk fat globule membranes (Newman et al., 1980) . Class II may be induced by exogenous administration of prolactin, suggesting a hormonal regulation of Ia antigens in the mammary gland and a possible correlation with the differentiation process (Klareskog et al., 1980; Bernard et al., 1986a Bernard et al., , 1990 ).
In addition, other studies have reported the expression of HLA class II Ags on some malignant tissues of nonlymphoid origin as melanoma (Houghton et al., 1982) ; adenocarcinoma from the stomach, the colon, the sigmoidal anse, the rectum, the spleen, the lung and the ovary; thymic carcinoma, prostate carcinoma, breast medullary carcinoma, bladder carcinoma, cystic astrocytoma, ganglioneuroblastoma, glioblastoma, and meningioma (Howe et al., 1981; Natali et al., 1981; Ng et al., 1981) .
Epidermal growth factor (EGF) has been shown to stimulate in vitro growth of epithelial cells derived both from normal breast and mammary carcinomas and that EGF may play a role in regulating growth of breast cancer cells in vivo (Fitzpatrick et al., 1984) .
In this work, we define and analyse cell-surface expression and RNA transcripts of class I and class II before and after EGF treatment to determine whether this response was variable in different tumour cell lines from the same origin.
Materials and methods

Cell lines and cultures
Two human breast carcinoma cell lines have been studied. They were derived from metastatic breast carcinomas: MCF7 (Soule et al., 1973) and T47D (Keydar et al., 1979) . These cell lines were cultured in closed plastic T75 flasks (Corning, New York 14830), in growth medium composed of RPMI 1640 (Gibco Europe Ltd, Renfrewshire, Scotland), buffered with 2 gl-' sodium bicarbonate, supplemented with 10% foetal calf serum, 2 mM L-glutamine, 50 UI ml-' penicillin and 50 fig ml-' streptomycin. For MCF7 cell line, 0.04 U ml-' insulin was added to growth medium. Cells were grown in a humidified incubator with 5% CO2 at 37°C. Cultures were refed every 2 to 3 days. Culturing (after I week growth) involved trypsin digestion (7.5 mg in 3 ml-' PBS for a flask), to obtain monocellular suspensions followed by the plating of 3 x 106 cells/flask. Cultures were confluent after 1 week (approximately 10 x 106 cells/flask).
In assays of the EGF effects on class I and class II HLA Ag expression, cells were grown for one week (with a refeeding to day 3). Immediately after cell passage, 30 ml of medium (supplemented as described above) were added with EGF to a final concentration of 0.02 jig ml -) of culture.
In parallel, control cells without any treatment were refed and collected at the same time with EFG-treated cells.
Raji cell line was grown in closed plastic T75 flasks (Corning, New-York 14830) in RPMI 1640 supplemented with 10% foetal calf serum (Pulvertaft, 1965) (Bernard et al., 1984a (Bernard et al., ,b, 1985 (Bernard et al., , 1990 Table I . With our quantification method, we found in MCF7 cell line that the expression of HLA class I Ags increased 7-fold and HLA class II (DR) Ags 10-fold when stimulation with EGF (0.02j iml-' culture medium) was performed. Meanwhile, in T47D cell line, HLA class I Ags increased 3-fold, and HLA class II (DR) Ags increased 4-fold after EGF stimulation (0.02 fLg ml-' culture medium).
Discussion
This work was undertaken to determine qualitative and quantitative changes induced in HLA class I and class II molecules by EGF in two human breast adenocarcinoma cell lines: MCF7 and T47D. To this purpose, qualitative changes in HLA class I and class II RNA were realised with Northern blotting and quantification of Ags class I and class II (DR) was performed with MoAb-binding studies.
In this study, we demonstrated that EGF increased only class I RNA expression in a breast adenocarcinoma cell line, MCF7, but the rates remained slower than in lymphoblastoid cells (Raji). Moreover, no change was obtained for RNA class I in T47D cells after EGF stimulation. Besides, we found an increase in class I surface-antigen expression in T47D cell line and in MCF7 cells but it was smaller in T47D cell line.
For class II MHC Ags which showed a limited tissue distribution in vivo and are involved in the presentation of Ag to T-helper cells; EGF significantly increased the class II DRa RNA and the expression of surface DR Ags in MCF7 cells. For T47D cells, after EGF stimulation, the increased change for DRa RNA and DR Ag expression are weaker than in MCF7 cells. Moreover, this discordance in RNA between the two loci (DR and DQ) and the different cell lines may reflect a locus-independant regulation and a different degree of differentiation. It may also imply other transcriptional regulatory factors (De Preval, 1988; Yunis et al., 1989) .
EGF appeared to act as an inducer of HLA class I, HLA class II in breast adenocarcinomas. The functional significance of increased class II Ag expression in neoplastic tissues may play a role in antigen presentation.
Furthermore, increased expression of EGF receptor has been found in a variety of tumours: glioblastomas, squamous-cell carcinomas (Merlino et al., 1984; Ullrich et al., 1984; Libermann et al., 1985; Yamamoto et al., 1986) , human breast cancer cell lines and in membrane prepared from breast cancer biopsies (Fitzpatrick et al., 1982 (Fitzpatrick et al., , 1984 Lebeau & Goubin, 1987) .
On the other hand, associations between HLA class I molecules and cell-surface receptors for various growth factors and hormones have been well documented (Haliotis et al., 1990) . Receptors thought to associate with class I molecules are numerous but include epidermal growth factor. Shreiber et al. (1984) had used a monoclonal antibody to human class I antigens, HLA-A, B, C, to probe the interaction of these antigens with the receptor for EGF in intact cells. They showed that in two different cell types, human tumour cells and normal human fibroblasts, the binding of antibody to HLA antigens alters the display of EGF receptors, while binding of EGF to its receptors affects the binding of antibody to HLA.
In many previous publications, we have already reported the hormonal modulation of HLA class II molecules for neoplastic non-hematopoietic-derived tissues such as Nnitroso-N-methylurea (NMU)-induced rat mammary carcinoma and MCF7 breast tumour cell line. An increase in the expression of HLA class II antigens was observed after treatment with prolactin, and a decrease was seen after treatment with 2a-bromoergocryptine (an inhibitor of pituitary prolactin secretion). These treatments did not modify the total prolactin receptor amounts in NMU-induced rat mammary tumours (Bernard et al., 1986b) . Effectiveness of prolactin on the induction of HLA class II antigens was also demonstrated in vitro for the human breast cancer cell line MCF7 (Bernard et al., 1986a) which possesses specific prolactin receptors with a higher density than normal human mammary cell lines (Shiu et al., 1979) . Moreover, we had investigated the negative effects of cyclosporine A (an immunosuppressive agent) on the expression of HLA class II antigens, resulting from a competition between cyclosporine and prolactin to the prolactin receptors. A significant decrease was obtained in HLA class II antigen expression by NMU-induced mammary tumours of animals treated with cyclosporine A because cyclosporine A acts as an antagonist to prolactin receptors in such hormonedependent mammary cancer (Bernard et al., 1990) . Further evidence of antagonism of prolactin binding to prolactin receptors by cyclosporine A was demonstrated on a breast tumour cell line (MCF7) by measuring the decreased specific '25I-labelled prolactin-binding to prolactin receptors with increasing concentrations of cyclosporine A (Bernard et al., 1991) .
At the same time, we had also studied the ovarian hormone modulation of HLA class II antigens expressed by the NMU-induced rat mammary tumour cells. The administration of 17p-estradiol was highly effective in decreasing the expression of HLA class II antigens and conversely progesterone was without any effect on expression of HLA class II antigen expression when compared with the rat control group receiving only NMU (Bernard et al., 1989 Further studies are now required to define better the regulation of HLA molecules in cancer surveillance.
